PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 228 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,288,011 | -38.1% | 13,447,666 | -1.5% | 0.09% | -34.8% |
| Q2 2023 | $181,544,308 | +11.9% | 13,649,948 | -2.5% | 0.14% | +16.5% |
| Q1 2023 | $162,195,444 | +40.0% | 14,006,515 | -1.1% | 0.12% | +31.5% |
| Q4 2022 | $115,879,459 | +38.7% | 14,166,193 | -1.6% | 0.09% | +33.3% |
| Q3 2022 | $83,545,000 | +31.8% | 14,391,962 | +0.3% | 0.07% | +40.8% |
| Q2 2022 | $63,407,000 | -50.3% | 14,345,485 | +2.3% | 0.05% | -42.4% |
| Q1 2022 | $127,593,000 | -47.7% | 14,021,205 | +17.7% | 0.08% | -42.6% |
| Q4 2021 | $243,781,000 | +2.1% | 11,915,025 | +27.5% | 0.15% | -0.7% |
| Q3 2021 | $238,841,000 | -16.0% | 9,348,002 | +14.9% | 0.15% | -11.3% |
| Q2 2021 | $284,387,000 | +64.1% | 8,132,325 | +56.3% | 0.17% | +55.6% |
| Q1 2021 | $173,322,000 | +49.2% | 5,203,313 | +16.2% | 0.11% | +44.0% |
| Q4 2020 | $116,162,000 | +185.9% | 4,478,094 | +8.8% | 0.08% | +177.8% |
| Q3 2020 | $40,630,000 | – | 4,116,553 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrone Advisors, LLC | 16,415,933 | $137,073,041 | 29.47% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,638,395 | $13,680,598 | 4.20% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $12,223,331 | 4.08% |
| VK Services, LLC | 2,632,784 | $21,983,746 | 2.93% |
| Iron Triangle Partners LP | 1,800,000 | $15,030,000 | 2.20% |
| BOURNE LENT ASSET MANAGEMENT INC | 574,350 | $4,795,822 | 2.11% |
| Deep Track Capital, LP | 6,000,000 | $50,100,000 | 1.93% |
| Jackson Square Partners, LLC | 6,933,865 | $57,897,773 | 1.93% |
| ARK Investment Management | 29,822,440 | $249,017,370 | 1.90% |
| Nikko Asset Management Americas, Inc. | 13,447,666 | $112,153,534 | 1.34% |